Pr Laurent Greillier

Specialty

Oncologist, lung expert

Title

Head of department

Hospital

AP-HM Hôpital Nord (Marseille)

Latest articles

• Adjuvant chemotherapy for stage IA-IIA non-squamous, non-small-cell lung cancer identified as molecular high-risk by a 14-gene expression profile (AIM-HIGH): an international, randomised, phase 3 trial. (Jun 24, 2025)
• Regression of Retinal Metastasis with Combined Chemotherapy and Immunotherapy. (Jun 6, 2025)
• Genetic biomarker study of sunvozertinib for clinical prognosis and prediction in NSCLC with EGFR exon 20 insertion mutation. (May 20, 2025)
• Pharmacology and pharmacokinetics of antibody-drug conjugates, where do we stand? (Apr 1, 2025)
• [Recommendations for the management of oligometatic NSCLC]. (Mar 1, 2025)